BackSepterna Overview
Septerna, Inc.

Septerna Target Price

Where could SEPN trade next? Consensus target price: $52.

Get informed when a big investor buys or sells

+ Follow

Share Price

$42.6

Average Target Price

$52.2522.7% upside

4 analysts in the last 4 months

High: $60 | Low: $49

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-12H.C. Wainwright$6040.8% upsideOpen
2026-08-11Raymond James$4915% upsideOpen
2026-08-11Stifel NicolausAlex Thompson$4915% upsideOpen
2026-08-11Guggenheim$5119.7% upsideOpen
2026-07-01Guggenheim$455.6% upsideOpen
2026-07-01Truist Financial$430.9% upsideOpen
2026-06-11Guggenheim$5222.1% upsideOpen
2026-06-08Raymond James$5324.4% upsideOpen
2026-03-10Cantor FitzgeraldJosh Schimmer$6040.8% upsideOpen
2026-01-20H.C. Wainwright$3517.8% downsideOpen
2025-12-19Raymond JamesMartin Auster$3810.8% downsideOpen
2025-12-15Truist Financial$3420.2% downsideOpen
2025-11-14Wells FargoDerek Archila$2834.3% downsideOpen
2025-05-16Wells FargoDerek Archila$1857.7% downsideOpen
2025-03-28Wells Fargo$1174.2% downsideOpen
2025-02-18Wells FargoDerek Archila$1467.1% downsideOpen

Septerna (SEPN) FAQ

Septerna (SEPN) currently reports a target price of $52. Use the charts on this page to explore Septerna's target price history and peer comparisons.

Analysts' average 12-month price target for Septerna is $52, about 22.7% upside from the current share price of $42.6. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $52, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Septerna, and consider following SEPN for alerts when major investors trade the stock.

Septerna is classified in the Healthcare sector. On target price, it currently shows $52. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SEPN with unrelated industries.